A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors.

被引：1
|
作者：
Infante, Jeffrey R.
Naing, Aung
Papadopoulos, Kyriakos P.
Autio, Karen A.
Ott, Patrick Alexander
Wong, Deborah Jean Lee
Falchook, Gerald Steven
Patel, Manish R.
Pant, Shubham
Whiteside, Melinda
Bendell, Johanna C.
Bauer, Todd Michael
Janku, Filip
Javle, Milind M.
Hong, David S.
Oft, Martin
机构：
[1] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] START Ctr Canc Care, San Antonio, TX USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Univ Calif Los Angeles, Los Angeles, CA USA
[7] Sarah Cannon Res Inst HealthONE, Denver, CO USA
[8] Sarah Cannon Res Inst Florida Canc Specialists, Sarasota, FL USA
[9] Univ Oklahoma, Hlth Sci Ctr, Sarah Cannon Res Inst, Oklahoma City, OK USA
[10] ARMO BioSci, Redwood City, CA USA
[11] Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN USA
[12] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.3017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3017
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A first-in-human study of pegylated recombinant human IL-10 (AM0010), daily administered for four months in selected advanced solid tumors.
    Bauer, Todd Michael
    Papadopoulos, Kyriakos P.
    Autio, Karen A.
    Ott, Patrick Alexander
    Whiteside, Melinda
    Oft, Martin
    Infante, Jeffrey R.
    Hod, F. Stephen
    Wolchok, Jedd I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] PEGylated human IL-10 (AM0010) in advanced solid tumors
    Naing, A.
    Infante, J. R.
    Papadopoulos, K.
    Autio, K.
    Ott, P.
    Wong, D.
    Falchook, G. S.
    Patel, M. R.
    Pant, S.
    Oft, M.
    ANNALS OF ONCOLOGY, 2015, 26 : 1 - 2
  • [3] Anti-tumor activity of PEGylated human IL-10 (AM0010) in patients with advanced solid tumors
    Infante, Jeffrey R.
    Naing, Aung
    Papadopoulos, Kyriakos P.
    Autio, Karen A.
    Ott, Patrick A.
    Wong, Deborah J.
    Falchook, Gerald S.
    Patel, Manish
    Pant, Shubham
    Whiteside, Melinda
    Mumm, John B.
    Chan, Ivan H.
    Bendell, Johanna C.
    Bauer, Todd M.
    Janku, Filip
    Javle, Milind
    Colen, Rivka R.
    Tannir, Nizar M.
    Oft, Martin
    CANCER RESEARCH, 2016, 76
  • [4] SAFETY AND ANTI-TUMOUR ACTIVITY OF PEGYLATED RECOMBINANT HUMAN IL-10 (AM0010) IN SELECTED ADVANCED SOLID TUMOURS
    Naing, A.
    Infante, J. R.
    Papadopoulos, K. P.
    Autio, K. A.
    Ott, P. A.
    Falchook, G.
    Wong, D.
    Whiteside, M.
    Oft, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : E22 - E22
  • [5] Safety, immune activation and anti-tumor efficacy of PEGylated recombinant human IL-10 (AM0010) in patients with advanced solid tumors - a phase 1 study
    Naing, A.
    Infante, J. R.
    Papadopoulos, K. P.
    Autio, K. A.
    Ott, P. A.
    Wong, D. J.
    Falchook, G. S.
    Patel, M. R.
    Pant, S.
    Whiteside, M.
    Bendell, J. C.
    Bauer, T. M.
    Janku, F.
    Tannir, N. M.
    Oft, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : S3 - S3
  • [6] PEGylated human IL-10 (AM0010) in combination with an anti-PD-1 in advanced NSCLC
    Wong, D.
    Schneider, J. G.
    Aljumaily, R.
    Korn, W. M.
    Infante, J.
    Patel, M.
    Autio, K.
    Papadopoulos, K.
    Naing, A.
    Gabrail, N. Y.
    Munster, P.
    Goldman, J.
    Ratti, N.
    Van Vlasselaer, P.
    Hung, A.
    Oft, M.
    Garon, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] PEGylated human IL-10 (AM0010) monotherapy in refractory metastatic colorectal cancer.
    Infante, Jeffrey R.
    Papadopoulos, Kyriakos P.
    Naing, Aung
    Autio, Karen A.
    Ott, Patrick Alexander
    Wong, Deborah Jean Lee
    Bendel, Johanna C.
    Bauer, Todd Michael
    Pant, Shubham
    Van Vlasselaer, Peter
    Brown, Gail Linda
    Oft, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors
    Naing, Aung
    Papadopoulos, Kyriakos P.
    Autio, Karen A.
    Ott, Patrick A.
    Patel, Manish R.
    Wong, Deborah J.
    Falchook, Gerald S.
    Pant, Shubham
    Whiteside, Melinda
    Rasco, Drew R.
    Mumm, John B.
    Chan, Ivan H.
    Bendell, Johanna C.
    Bauer, Todd M.
    Colen, Rivka R.
    Hong, David S.
    Van Vlasselaer, Peter
    Tannir, Nizar M.
    Oft, Martin
    Infante, Jeffrey R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (29) : 3562 - +
  • [9] Immune correlates for the efficacy of PEGylated Human IL-10 (AM0010) with nivolumab in renal cell cancer
    Naing, A.
    Infante, J. R.
    Wong, D. J.
    Korn, M. W.
    Aljumaily, R.
    Papadopoulos, K.
    Autio, K.
    Pant, S.
    Bauer, T. M.
    Drakaki, A.
    Daver, N.
    Hung, A.
    Van Vlasselaer, P.
    Brown, G.
    Oft, M.
    Tannir, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] First-in-human dose escalation study of oral ONC201 in advanced solid tumors.
    Stein, Mark N.
    Mayer, Tina M.
    Moss, Rebecca Anne
    Silk, Ann W.
    Chan, Nancy
    Haffty, Bruce George
    DiPaola, Robert S.
    Beckett, Yasmeen
    Bentlyewski, Edward
    Zheng, Ling
    Fang, Bruno
    Allen, Joshua
    Mehnert, Janice M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345